カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のゼラチンペプチド血漿代替品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Gelatin Peptide Plasma Substitute Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19344）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19344
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のゼラチンペプチド血漿代替品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ゼラチンペプチド血漿代替品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のゼラチンペプチド血漿代替品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ゼラチンペプチド血漿代替品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・尿素架橋ゼラチンポリペプチド、コハク酸ゼラチンポリペプチド、ポリゼラチンペプチド

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界のゼラチンペプチド血漿代替品市場の主要な市場プレーヤーは以下のとおりです。
・B. Braun Melsungen AG、Wuhan Hualong Bio-pharmaceutical、CSL Behring、Rousselot、GELITA、PB Leiner、Baotou Dongbao Bio-tech

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ゼラチンペプチド血漿代替品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なゼラチンペプチド血漿代替品メーカーの企業概要、2019年～2022年までのゼラチンペプチド血漿代替品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なゼラチンペプチド血漿代替品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ゼラチンペプチド血漿代替品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのゼラチンペプチド血漿代替品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのゼラチンペプチド血漿代替品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびゼラチンペプチド血漿代替品の産業チェーンを掲載しています。
・第13、14、15章では、ゼラチンペプチド血漿代替品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ゼラチンペプチド血漿代替品の概要
- 種類別分析（2017年vs2021年vs2028年）：尿素架橋ゼラチンポリペプチド、コハク酸ゼラチンポリペプチド、ポリゼラチンペプチド
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界のゼラチンペプチド血漿代替品市場規模・予測
- 世界のゼラチンペプチド血漿代替品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- B. Braun Melsungen AG、Wuhan Hualong Bio-pharmaceutical、CSL Behring、Rousselot、GELITA、PB Leiner、Baotou Dongbao Bio-tech
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：尿素架橋ゼラチンポリペプチド、コハク酸ゼラチンポリペプチド、ポリゼラチンペプチド
・用途別分析2017年-2028年：病院、診療所、その他
・ゼラチンペプチド血漿代替品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ゼラチンペプチド血漿代替品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ゼラチンペプチド血漿代替品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ゼラチンペプチド血漿代替品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ゼラチンペプチド血漿代替品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Gelatin Peptide Plasma Substitute market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gelatin Peptide Plasma Substitute market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Gelatin Peptide Plasma Substitute global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Urea Bridged Gelatin Polypeptide segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gelatin Peptide Plasma Substitute include B. Braun Melsungen AG, Wuhan Hualong Bio-pharmaceutical, CSL Behring, Rousselot, and GELITA, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gelatin Peptide Plasma Substitute market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Urea Bridged Gelatin Polypeptide
Succinic Acid Gelatin Polypeptide
Poly Gelatin Peptide
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Gelatin Peptide Plasma Substitute market are listed below:
B. Braun Melsungen AG
Wuhan Hualong Bio-pharmaceutical
CSL Behring
Rousselot
GELITA
PB Leiner
Baotou Dongbao Bio-tech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gelatin Peptide Plasma Substitute product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gelatin Peptide Plasma Substitute, with price, sales, revenue and global market share of Gelatin Peptide Plasma Substitute from 2019 to 2022.
Chapter 3, the Gelatin Peptide Plasma Substitute competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gelatin Peptide Plasma Substitute breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gelatin Peptide Plasma Substitute market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gelatin Peptide Plasma Substitute.
Chapter 13, 14, and 15, to describe Gelatin Peptide Plasma Substitute sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Gelatin Peptide Plasma Substitute Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gelatin Peptide Plasma Substitute Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Urea Bridged Gelatin Polypeptide
1.2.3 Succinic Acid Gelatin Polypeptide
1.2.4 Poly Gelatin Peptide
1.3 Market Analysis by Application
1.3.1 Overview: Global Gelatin Peptide Plasma Substitute Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Gelatin Peptide Plasma Substitute Market Size & Forecast
1.4.1 Global Gelatin Peptide Plasma Substitute Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gelatin Peptide Plasma Substitute Sales in Volume (2017-2028)
1.4.3 Global Gelatin Peptide Plasma Substitute Price (2017-2028)
1.5 Global Gelatin Peptide Plasma Substitute Production Capacity Analysis
1.5.1 Global Gelatin Peptide Plasma Substitute Total Production Capacity (2017-2028)
1.5.2 Global Gelatin Peptide Plasma Substitute Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gelatin Peptide Plasma Substitute Market Drivers
1.6.2 Gelatin Peptide Plasma Substitute Market Restraints
1.6.3 Gelatin Peptide Plasma Substitute Trends Analysis
2 Manufacturers Profiles
2.1 B. Braun Melsungen AG
2.1.1 B. Braun Melsungen AG Details
2.1.2 B. Braun Melsungen AG Major Business
2.1.3 B. Braun Melsungen AG Gelatin Peptide Plasma Substitute Product and Services
2.1.4 B. Braun Melsungen AG Gelatin Peptide Plasma Substitute Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Wuhan Hualong Bio-pharmaceutical
2.2.1 Wuhan Hualong Bio-pharmaceutical Details
2.2.2 Wuhan Hualong Bio-pharmaceutical Major Business
2.2.3 Wuhan Hualong Bio-pharmaceutical Gelatin Peptide Plasma Substitute Product and Services
2.2.4 Wuhan Hualong Bio-pharmaceutical Gelatin Peptide Plasma Substitute Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL Behring
2.3.1 CSL Behring Details
2.3.2 CSL Behring Major Business
2.3.3 CSL Behring Gelatin Peptide Plasma Substitute Product and Services
2.3.4 CSL Behring Gelatin Peptide Plasma Substitute Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Rousselot
2.4.1 Rousselot Details
2.4.2 Rousselot Major Business
2.4.3 Rousselot Gelatin Peptide Plasma Substitute Product and Services
2.4.4 Rousselot Gelatin Peptide Plasma Substitute Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GELITA
2.5.1 GELITA Details
2.5.2 GELITA Major Business
2.5.3 GELITA Gelatin Peptide Plasma Substitute Product and Services
2.5.4 GELITA Gelatin Peptide Plasma Substitute Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 PB Leiner
2.6.1 PB Leiner Details
2.6.2 PB Leiner Major Business
2.6.3 PB Leiner Gelatin Peptide Plasma Substitute Product and Services
2.6.4 PB Leiner Gelatin Peptide Plasma Substitute Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Baotou Dongbao Bio-tech
2.7.1 Baotou Dongbao Bio-tech Details
2.7.2 Baotou Dongbao Bio-tech Major Business
2.7.3 Baotou Dongbao Bio-tech Gelatin Peptide Plasma Substitute Product and Services
2.7.4 Baotou Dongbao Bio-tech Gelatin Peptide Plasma Substitute Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gelatin Peptide Plasma Substitute Breakdown Data by Manufacturer
3.1 Global Gelatin Peptide Plasma Substitute Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gelatin Peptide Plasma Substitute Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gelatin Peptide Plasma Substitute
3.4 Market Concentration Rate
3.4.1 Top 3 Gelatin Peptide Plasma Substitute Manufacturer Market Share in 2021
3.4.2 Top 6 Gelatin Peptide Plasma Substitute Manufacturer Market Share in 2021
3.5 Global Gelatin Peptide Plasma Substitute Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gelatin Peptide Plasma Substitute Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gelatin Peptide Plasma Substitute Market Size by Region
4.1.1 Global Gelatin Peptide Plasma Substitute Sales in Volume by Region (2017-2028)
4.1.2 Global Gelatin Peptide Plasma Substitute Revenue by Region (2017-2028)
4.2 North America Gelatin Peptide Plasma Substitute Revenue (2017-2028)
4.3 Europe Gelatin Peptide Plasma Substitute Revenue (2017-2028)
4.4 Asia-Pacific Gelatin Peptide Plasma Substitute Revenue (2017-2028)
4.5 South America Gelatin Peptide Plasma Substitute Revenue (2017-2028)
4.6 Middle East and Africa Gelatin Peptide Plasma Substitute Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gelatin Peptide Plasma Substitute Sales in Volume by Type (2017-2028)
5.2 Global Gelatin Peptide Plasma Substitute Revenue by Type (2017-2028)
5.3 Global Gelatin Peptide Plasma Substitute Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gelatin Peptide Plasma Substitute Sales in Volume by Application (2017-2028)
6.2 Global Gelatin Peptide Plasma Substitute Revenue by Application (2017-2028)
6.3 Global Gelatin Peptide Plasma Substitute Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gelatin Peptide Plasma Substitute Sales by Type (2017-2028)
7.2 North America Gelatin Peptide Plasma Substitute Sales by Application (2017-2028)
7.3 North America Gelatin Peptide Plasma Substitute Market Size by Country
7.3.1 North America Gelatin Peptide Plasma Substitute Sales in Volume by Country (2017-2028)
7.3.2 North America Gelatin Peptide Plasma Substitute Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gelatin Peptide Plasma Substitute Sales by Type (2017-2028)
8.2 Europe Gelatin Peptide Plasma Substitute Sales by Application (2017-2028)
8.3 Europe Gelatin Peptide Plasma Substitute Market Size by Country
8.3.1 Europe Gelatin Peptide Plasma Substitute Sales in Volume by Country (2017-2028)
8.3.2 Europe Gelatin Peptide Plasma Substitute Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gelatin Peptide Plasma Substitute Sales by Type (2017-2028)
9.2 Asia-Pacific Gelatin Peptide Plasma Substitute Sales by Application (2017-2028)
9.3 Asia-Pacific Gelatin Peptide Plasma Substitute Market Size by Region
9.3.1 Asia-Pacific Gelatin Peptide Plasma Substitute Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gelatin Peptide Plasma Substitute Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gelatin Peptide Plasma Substitute Sales by Type (2017-2028)
10.2 South America Gelatin Peptide Plasma Substitute Sales by Application (2017-2028)
10.3 South America Gelatin Peptide Plasma Substitute Market Size by Country
10.3.1 South America Gelatin Peptide Plasma Substitute Sales in Volume by Country (2017-2028)
10.3.2 South America Gelatin Peptide Plasma Substitute Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gelatin Peptide Plasma Substitute Sales by Type (2017-2028)
11.2 Middle East & Africa Gelatin Peptide Plasma Substitute Sales by Application (2017-2028)
11.3 Middle East & Africa Gelatin Peptide Plasma Substitute Market Size by Country
11.3.1 Middle East & Africa Gelatin Peptide Plasma Substitute Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gelatin Peptide Plasma Substitute Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gelatin Peptide Plasma Substitute and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gelatin Peptide Plasma Substitute
12.3 Gelatin Peptide Plasma Substitute Production Process
12.4 Gelatin Peptide Plasma Substitute Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gelatin Peptide Plasma Substitute Typical Distributors
13.3 Gelatin Peptide Plasma Substitute Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Gelatin Peptide Plasma Substitute Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gelatin Peptide Plasma Substitute Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 4. B. Braun Melsungen AG Major Business
Table 5. B. Braun Melsungen AG Gelatin Peptide Plasma Substitute Product and Services
Table 6. B. Braun Melsungen AG Gelatin Peptide Plasma Substitute Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Wuhan Hualong Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Wuhan Hualong Bio-pharmaceutical Major Business
Table 9. Wuhan Hualong Bio-pharmaceutical Gelatin Peptide Plasma Substitute Product and Services
Table 10. Wuhan Hualong Bio-pharmaceutical Gelatin Peptide Plasma Substitute Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 12. CSL Behring Major Business
Table 13. CSL Behring Gelatin Peptide Plasma Substitute Product and Services
Table 14. CSL Behring Gelatin Peptide Plasma Substitute Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Rousselot Basic Information, Manufacturing Base and Competitors
Table 16. Rousselot Major Business
Table 17. Rousselot Gelatin Peptide Plasma Substitute Product and Services
Table 18. Rousselot Gelatin Peptide Plasma Substitute Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GELITA Basic Information, Manufacturing Base and Competitors
Table 20. GELITA Major Business
Table 21. GELITA Gelatin Peptide Plasma Substitute Product and Services
Table 22. GELITA Gelatin Peptide Plasma Substitute Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. PB Leiner Basic Information, Manufacturing Base and Competitors
Table 24. PB Leiner Major Business
Table 25. PB Leiner Gelatin Peptide Plasma Substitute Product and Services
Table 26. PB Leiner Gelatin Peptide Plasma Substitute Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Baotou Dongbao Bio-tech Basic Information, Manufacturing Base and Competitors
Table 28. Baotou Dongbao Bio-tech Major Business
Table 29. Baotou Dongbao Bio-tech Gelatin Peptide Plasma Substitute Product and Services
Table 30. Baotou Dongbao Bio-tech Gelatin Peptide Plasma Substitute Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Gelatin Peptide Plasma Substitute Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Gelatin Peptide Plasma Substitute Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Gelatin Peptide Plasma Substitute, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Gelatin Peptide Plasma Substitute Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Gelatin Peptide Plasma Substitute Production Site of Key Manufacturer
Table 36. Gelatin Peptide Plasma Substitute New Entrant and Capacity Expansion Plans
Table 37. Gelatin Peptide Plasma Substitute Mergers & Acquisitions in the Past Five Years
Table 38. Global Gelatin Peptide Plasma Substitute Sales by Region (2017-2022) & (K Units)
Table 39. Global Gelatin Peptide Plasma Substitute Sales by Region (2023-2028) & (K Units)
Table 40. Global Gelatin Peptide Plasma Substitute Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Gelatin Peptide Plasma Substitute Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Gelatin Peptide Plasma Substitute Sales by Type (2017-2022) & (K Units)
Table 43. Global Gelatin Peptide Plasma Substitute Sales by Type (2023-2028) & (K Units)
Table 44. Global Gelatin Peptide Plasma Substitute Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Gelatin Peptide Plasma Substitute Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Gelatin Peptide Plasma Substitute Price by Type (2017-2022) & (USD/Unit)
Table 47. Global Gelatin Peptide Plasma Substitute Price by Type (2023-2028) & (USD/Unit)
Table 48. Global Gelatin Peptide Plasma Substitute Sales by Application (2017-2022) & (K Units)
Table 49. Global Gelatin Peptide Plasma Substitute Sales by Application (2023-2028) & (K Units)
Table 50. Global Gelatin Peptide Plasma Substitute Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Gelatin Peptide Plasma Substitute Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Gelatin Peptide Plasma Substitute Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Gelatin Peptide Plasma Substitute Price by Application (2023-2028) & (USD/Unit)
Table 54. North America Gelatin Peptide Plasma Substitute Sales by Country (2017-2022) & (K Units)
Table 55. North America Gelatin Peptide Plasma Substitute Sales by Country (2023-2028) & (K Units)
Table 56. North America Gelatin Peptide Plasma Substitute Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Gelatin Peptide Plasma Substitute Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Gelatin Peptide Plasma Substitute Sales by Type (2017-2022) & (K Units)
Table 59. North America Gelatin Peptide Plasma Substitute Sales by Type (2023-2028) & (K Units)
Table 60. North America Gelatin Peptide Plasma Substitute Sales by Application (2017-2022) & (K Units)
Table 61. North America Gelatin Peptide Plasma Substitute Sales by Application (2023-2028) & (K Units)
Table 62. Europe Gelatin Peptide Plasma Substitute Sales by Country (2017-2022) & (K Units)
Table 63. Europe Gelatin Peptide Plasma Substitute Sales by Country (2023-2028) & (K Units)
Table 64. Europe Gelatin Peptide Plasma Substitute Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Gelatin Peptide Plasma Substitute Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Gelatin Peptide Plasma Substitute Sales by Type (2017-2022) & (K Units)
Table 67. Europe Gelatin Peptide Plasma Substitute Sales by Type (2023-2028) & (K Units)
Table 68. Europe Gelatin Peptide Plasma Substitute Sales by Application (2017-2022) & (K Units)
Table 69. Europe Gelatin Peptide Plasma Substitute Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Gelatin Peptide Plasma Substitute Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Gelatin Peptide Plasma Substitute Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Gelatin Peptide Plasma Substitute Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Gelatin Peptide Plasma Substitute Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Gelatin Peptide Plasma Substitute Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Gelatin Peptide Plasma Substitute Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Gelatin Peptide Plasma Substitute Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Gelatin Peptide Plasma Substitute Sales by Application (2023-2028) & (K Units)
Table 78. South America Gelatin Peptide Plasma Substitute Sales by Country (2017-2022) & (K Units)
Table 79. South America Gelatin Peptide Plasma Substitute Sales by Country (2023-2028) & (K Units)
Table 80. South America Gelatin Peptide Plasma Substitute Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Gelatin Peptide Plasma Substitute Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Gelatin Peptide Plasma Substitute Sales by Type (2017-2022) & (K Units)
Table 83. South America Gelatin Peptide Plasma Substitute Sales by Type (2023-2028) & (K Units)
Table 84. South America Gelatin Peptide Plasma Substitute Sales by Application (2017-2022) & (K Units)
Table 85. South America Gelatin Peptide Plasma Substitute Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Gelatin Peptide Plasma Substitute Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Gelatin Peptide Plasma Substitute Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Gelatin Peptide Plasma Substitute Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Gelatin Peptide Plasma Substitute Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Gelatin Peptide Plasma Substitute Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Gelatin Peptide Plasma Substitute Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Gelatin Peptide Plasma Substitute Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Gelatin Peptide Plasma Substitute Sales by Application (2023-2028) & (K Units)
Table 94. Gelatin Peptide Plasma Substitute Raw Material
Table 95. Key Manufacturers of Gelatin Peptide Plasma Substitute Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Gelatin Peptide Plasma Substitute Typical Distributors
Table 99. Gelatin Peptide Plasma Substitute Typical Customers
List of Figures
Figure 1. Gelatin Peptide Plasma Substitute Picture
Figure 2. Global Gelatin Peptide Plasma Substitute Revenue Market Share by Type in 2021
Figure 3. Urea Bridged Gelatin Polypeptide
Figure 4. Succinic Acid Gelatin Polypeptide
Figure 5. Poly Gelatin Peptide
Figure 6. Global Gelatin Peptide Plasma Substitute Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Gelatin Peptide Plasma Substitute Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Gelatin Peptide Plasma Substitute Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Gelatin Peptide Plasma Substitute Sales (2017-2028) & (K Units)
Figure 13. Global Gelatin Peptide Plasma Substitute Price (2017-2028) & (USD/Unit)
Figure 14. Global Gelatin Peptide Plasma Substitute Production Capacity (2017-2028) & (K Units)
Figure 15. Global Gelatin Peptide Plasma Substitute Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Gelatin Peptide Plasma Substitute Market Drivers
Figure 17. Gelatin Peptide Plasma Substitute Market Restraints
Figure 18. Gelatin Peptide Plasma Substitute Market Trends
Figure 19. Global Gelatin Peptide Plasma Substitute Sales Market Share by Manufacturer in 2021
Figure 20. Global Gelatin Peptide Plasma Substitute Revenue Market Share by Manufacturer in 2021
Figure 21. Gelatin Peptide Plasma Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Gelatin Peptide Plasma Substitute Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Gelatin Peptide Plasma Substitute Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Gelatin Peptide Plasma Substitute Sales Market Share by Region (2017-2028)
Figure 25. Global Gelatin Peptide Plasma Substitute Revenue Market Share by Region (2017-2028)
Figure 26. North America Gelatin Peptide Plasma Substitute Revenue (2017-2028) & (USD Million)
Figure 27. Europe Gelatin Peptide Plasma Substitute Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Gelatin Peptide Plasma Substitute Revenue (2017-2028) & (USD Million)
Figure 29. South America Gelatin Peptide Plasma Substitute Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Gelatin Peptide Plasma Substitute Revenue (2017-2028) & (USD Million)
Figure 31. Global Gelatin Peptide Plasma Substitute Sales Market Share by Type (2017-2028)
Figure 32. Global Gelatin Peptide Plasma Substitute Revenue Market Share by Type (2017-2028)
Figure 33. Global Gelatin Peptide Plasma Substitute Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Gelatin Peptide Plasma Substitute Sales Market Share by Application (2017-2028)
Figure 35. Global Gelatin Peptide Plasma Substitute Revenue Market Share by Application (2017-2028)
Figure 36. Global Gelatin Peptide Plasma Substitute Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Gelatin Peptide Plasma Substitute Sales Market Share by Type (2017-2028)
Figure 38. North America Gelatin Peptide Plasma Substitute Sales Market Share by Application (2017-2028)
Figure 39. North America Gelatin Peptide Plasma Substitute Sales Market Share by Country (2017-2028)
Figure 40. North America Gelatin Peptide Plasma Substitute Revenue Market Share by Country (2017-2028)
Figure 41. United States Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Gelatin Peptide Plasma Substitute Sales Market Share by Type (2017-2028)
Figure 45. Europe Gelatin Peptide Plasma Substitute Sales Market Share by Application (2017-2028)
Figure 46. Europe Gelatin Peptide Plasma Substitute Sales Market Share by Country (2017-2028)
Figure 47. Europe Gelatin Peptide Plasma Substitute Revenue Market Share by Country (2017-2028)
Figure 48. Germany Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Gelatin Peptide Plasma Substitute Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Gelatin Peptide Plasma Substitute Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Gelatin Peptide Plasma Substitute Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Gelatin Peptide Plasma Substitute Revenue Market Share by Region (2017-2028)
Figure 57. China Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Gelatin Peptide Plasma Substitute Sales Market Share by Type (2017-2028)
Figure 64. South America Gelatin Peptide Plasma Substitute Sales Market Share by Application (2017-2028)
Figure 65. South America Gelatin Peptide Plasma Substitute Sales Market Share by Country (2017-2028)
Figure 66. South America Gelatin Peptide Plasma Substitute Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Gelatin Peptide Plasma Substitute Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Gelatin Peptide Plasma Substitute Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Gelatin Peptide Plasma Substitute Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Gelatin Peptide Plasma Substitute Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Gelatin Peptide Plasma Substitute Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Gelatin Peptide Plasma Substitute in 2021
Figure 78. Manufacturing Process Analysis of Gelatin Peptide Plasma Substitute
Figure 79. Gelatin Peptide Plasma Substitute Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のグルカゴン様ペプチド-2（GLP-2）アゴニスト市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用ゼラチンパウダー市場2022年：市場規模予測（～2028年）
  • 世界の生体吸収性移植代替物市場2022年：市場規模予測（～2028年）
  • 世界の医療用生体吸収性移植代替物市場2022年：市場規模予測（～2028年）
  • 世界の抗糖尿病グルカゴン様ペプチド1アゴニスト市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19344 )"世界のゼラチンペプチド血漿代替品市場2022年：市場規模予測（～2028年）" (英文：Global Gelatin Peptide Plasma Substitute Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。